Cost-utility and budget impact analysis of adding-on apremilast to biologic therapy in the treatment of moderate to severe plaque psoriasis, an Iranian payer perspective

por Zargaran, Marzieh, Soleymani, Fatemeh, Nasrollahi, Saman Ahmad, Seyedifar, Meysam, Rahaghi, Mohammad Mehdi Ashrafian
Publicado 2021